Anti-cyclic citrullinated peptide (CCP) antibodies in patients with long-standing rheumatoid arthritis and their relationship with extra-articular manifestations

Korkmaz, CENGİZ; Us, TERCAN; Kasifoglu, TİMUÇİN; Akgun, Yurdanur

doi:10.1016/j.clinbiochem.2006.06.004

Anti-cyclic citrullinated peptide (CCP) antibodies in patients with long-standing rheumatoid arthritis and their relationship with extra-articular manifestations

Atıf İçin Kopyala

Korkmaz C., Us T., Kasifoglu T., Akgun Y.

CLINICAL BIOCHEMISTRY, cilt.39, sa.10, ss.961-965, 2006 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 39 Sayı: 10
Basım Tarihi: 2006
Doi Numarası: 10.1016/j.clinbiochem.2006.06.004
Dergi Adı: CLINICAL BIOCHEMISTRY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.961-965
Anahtar Kelimeler: anti-CCP antibodies, rheumatoid arthritis, rheumatoid factor, extra-articular involvement, INFLIXIMAB TREATMENT, ASSOCIATION, AUTOANTIBODIES, SEVERITY
Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

Objectives: To evaluate frequency of anti-cyclic citrullinated peptide antibodies (anti-CCP) in long-standing rheumatoid arthritis (LsRA) patients and their relationship with extra-articular manifestations of rheumatoid arthritis (RA), in addition to comparing frequency of anti-CCP antibodies in early RA (ERA) and LsRA group.